Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients
Abstract
Background. Treatments for Helicobacter pylori (H. pylori) eradication include the use of antibiotics and a proton-pump inhibitor. Antibiotic resistance is a major concern for two drugs: levofloxacin and clarithromycin. The aim was to determine the prevalence of levofloxacin resistance (LevoR) and clarithromycin resistance (ClaR) in an urban population in Santiago, Chile.
Más información
Título según WOS: | Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients |
Título de la Revista: | ARCHIVES OF MEDICAL RESEARCH |
Volumen: | 52 |
Número: | 5 |
Editorial: | Elsevier Science Inc. |
Fecha de publicación: | 2021 |
Página de inicio: | 529 |
Página final: | 534 |
DOI: |
10.1016/J.ARCMED.2021.01.011 |
Notas: | ISI |